Dyne Therapeutics, Inc. · NASDAQ:DYN

Rhodes Jason P sold 504,695 Dyne Therapeutics, Inc. shares (Form 4)

Traded Jun 26 to Jun 29, 2026 · Filed Jun 30, 2026

From Jun 26 to Jun 29, 2026, Rhodes Jason P (Director) sold 504,695 Dyne Therapeutics, Inc. shares at an average US$21.23 for US$10.7M under a trading plan, leaving 975,931 shares. Filed Jun 30, 2026 (Form 4).

Sold
504,695 shares
Price
US$21.23 average (US$21.14 to US$21.28)
Value
US$10.7M
Holding after
975,931 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 26, 2026Common StockSale162,954US$21.284,579,456Indirect
Jun 26, 2026Common StockSale81,903US$21.281,396,475Indirect
Jun 26, 2026Common StockSale64,411US$21.281,016,633Indirect
Jun 29, 2026Common StockSale102,969US$21.144,476,487Indirect
Jun 29, 2026Common StockSale51,756US$21.141,344,719Indirect
Jun 29, 2026Common StockSale40,702US$21.14975,931Indirect

Source

View original at SEC

Related